Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Strong performance in exceptional times

· Rental income increased to SEK 1,142 million (1,124) · Income from property management increased to SEK 680 million (611) · Profit for the period declined to SEK 1,374 million (1,476) · Property portfolio increased to SEK 22,575 million (20,479) · Earnings per share declined to SEK 11.40 (12.19) · Year ends on positive note although lettings market bides its time · Platzer’s share classified as green · The Board of Directors proposes a dividend of SEK 2.10 per share (2.00), to be paid in two instalments of SEK 1.05 each AFTER THE END OF THE REPORTING PERIODLand

Qlife receives order from Statens Serum Institut for COVID-19 testing

Qlife announces today that Denmark’s infectious disease agency, Statens Serum Institut, has placed an order of 50 Egoo.Health devices and associated SARS-CoV-2 test capsules. The order represents a value of approximately 1 MDKK, and Qlife expects to complete the delivery in February 2021.“It is of great importance for Qlife to get a significant order from a highly professional customer directly after the CE-marking. It manifests the demand for tests of laboratory quality combined with fast results, which is exactly what the Egoo test delivers. The Egoo.Health platform is optimal for usage

Proposal of the Shareholders’ Nomination Board for the composition and remuneration of Tokmanni’s Board of Directors

Tokmanni Group Corporation        Stock exchange release        29 January 2021 at 9:00 amThe Shareholders’ Nomination Board of Tokmanni Group Corporation proposes to the Annual General Meeting that the number of the members of the Board of Directors remain the same and will be six. The Nomination Board proposes that the current members of the Board of Directors Seppo Saastamoinen, Harri Sivula, Therese Cedercreutz, Juha Blomster, Erkki Järvinen and Ulla Lettijeff will be re-elected. All proposed persons have granted their consent to the position. The information relevant considering

The electric vehicle company Inzile initiates international expansion - establishes sales company in Norway

The electric vehicle company Inzile begins its international expansion by establishing a sales company in Norway, with the purpose of selling Inzile's first product, the electric light truck Pro4. A salesman specifically focused on the Norwegian market has been recruited and negotiations are underway regarding the employment of a head of the sales company. - It feels natural that we begin our international expansion with our neighboring country Norway, says Inzile's CEO Ragnar Åhgren. Norway is at the forefront of the use of electric vehicles and we have for a long time experienced a

Saga Pure ASA: Notice to the Extraordinary General Meeting in Saga Pure ASA

The Extraordinary General Meeting in Saga Pure ASA will take place on 19 February 2021 at 10.00hrs (CET) at the premises of the Company at Sjolyst Plass 2, 7th floor in Oslo, Norway. Shareholders are requested to avail themselves of the possibilities of voting by proxy, as described in the notice of the meeting, and as far as possible to refrain from attending in person. Shareholders may submit their votes electronically in advance. Please see the instructions in the enclosed Notice. The Notice and the corresponding attachments will be available on the company's webpage www.

Increased number of shares and votes in Modern Times Group MTG AB (publ)

STOCKHOLM, January 29[th], 2021 – Modern Times Group MTG AB (publ) (“MTG”) announces that as of today, January 29[th] 2021, the total number of shares and votes in the company is 68,274,555 shares and 73,185,513 votes. The total number of shares is divided among 545,662 class A shares and 67,728,893 class B shares. Each class A share entitles to ten votes, and each class B share entitles to one vote, at general meetings of the company.The number of shares and votes has increased during January as a result of the issue of 627,431 new class B shares directed to certain sellers of Hutch Games

Change in the total number of shares and votes in Serneke

As of 29 January 2021, the total number of shares in Serneke Group AB (publ) (“Serneke”) amounts to 28,753,232 shares, divided into 5,210,000 shares of series A and 23,543,232 shares of series B. The total number of votes in Serneke as of 29 January 2021 amounts to 7,564,323.2.The number of shares and votes in Serneke has increased as a result of the registration of 3,204,780 shares of series B subscribed for by the exercise of subscription rights and subscribed for without subscription rights in Sernekes rights issue.   For more information, please contact: Robin Gerum, Director

Change of number of shares and votes in Readly

The number of shares and votes in Readly International AB (publ) (“Readly” or the “Company”) has changed as a result of exercise of warrants issued on 6 December 2017 and 7 May 2020.Through the subscription of shares through exercise of warrants, the number of outstanding shares and votes in the Company has increased by 195,169, from 37,031,448 to 37,226,617. Readly's registered share capital has increased by SEK 5,855, from SEK 1,110,943.44 to SEK 1,116,798.51. For more information, please contact: Annika Billberg, Head of Investor Relations Readly+46 70 267 97 91, annika.billberg@

Bonava’s year-end report 2020

Strong operating profit and cash flow and more projects started1 October – 31 December 2020 · Net sales amounted to SEK 7,553 M (6,499) · Operating profit* totalled SEK 910 M (693) · Operating margin* was 12.0 per cent (10.7) · Profit after financial items was SEK 873 M (504) · Profit for the period after tax amounted to SEK 640 M (368) · Cash flow before financing was SEK 1,918 M (969) · Earnings per share was SEK 5.97 (3.42) · Return on capital employed* was 7.9 per cent (8.1) · Sales value of housing units sold in the quarter amounted to SEK 6,218 M (5,335)

Stora Enso Oyj Financial Statement Release 2020

STORA ENSO OYJ, FINANCIAL STATEMENT RELEASE 29 January 2021 at 8.30 EETSteady performance as a result of our own actionsDividend proposal EUR 0.30 per shareQ4/2020 (year-on-year) · Sales decreased by 10.7% to EUR 2 154 (2 411) million, due to structural changes, lower prices and volumes. · Operational EBIT was EUR 118 (124) million, lower sales were mitigated by efficient cost management. · Operational EBIT margin increased to 5.5% (5.1%). · Operating profit (IFRS) decreased to EUR 289 (680) million. · EPS was EUR 0.30 (0.66) and EPS excl. fair valuations was EUR 0.09 (

Year-end report 2020: Higher deliveries and better capacity utilization improved earnings in Q4

The fourth quarter · Revenue was SEK 16,988 (16,973) million · EBITDA was SEK 1,439 (-127) million · Operating profit/loss was SEK 557 (-1,131) million · Earnings per share were SEK 0.33 (-1.21) · The Board proposes that no dividend will be paid for 2020Comments by the CEO The year 2020 was affected by a weak market as a consequence of Covid-19, and SSAB’s operating result fell to SEK -325 (2,159) million. The market picked up during the autumn and SSAB’s shipments and capacity utilization improved. This lifted earnings for the fourth quarter of 2020 to SEK 557 (-1,131)

Stora Enso will close its Virdia operations in the United States

STORA ENSO OYJ INVESTOR NEWS 29 January 2021 at 8:29 EETStora Enso has decided to permanently close its US-based Virdia operations during 2021. Virdia was acquired in 2014 and has focused on conversion of cellulosic biomass from sugar cane bagasse into refined sugars. The operations have consisted of a research centre in Danville, Virginia and a demo plant in Raceland, Louisiana, which will both be closed. The closure is in line with Stora Enso’s strategic choices in R&D to drive future growth and value creation from forest-based materials. Furthermore, today, the company’s innovation

Proposals by the Board of Directors to the Stora Enso Oyj Annual General Meeting 2021

STORA ENSO OYJ STOCK EXCHANGE RELEASE 29 January 2021 at 8:29 EETProposals by the Board of Directors to the Annual General Meeting 2021 The Board of Directors of Stora Enso Oyj (the "Company") has decided that the Annual General Meeting (the "AGM") will be held on Friday 19 March 2021 at 4 p.m. Finnish time with exceptional meeting procedures based on the temporary legislative act to limit the spread of the Covid-19 pandemic (677/2020). The AGM will be held without the presence of shareholders or their representatives in order to hold the meeting in a predictable manner, taking into

SSAB concludes IJmuiden discussions with Tata Steel

During the fourth quarter of 2020, SSAB announced that it was in discussions with Tata Steel concerning a possible acquisition of the IJmuiden steel mill and related downstream assets. After deeper analysis and discussions, it became clear that there were limited possibilities to integrate IJmuiden into the SSAB strategic framework. Discussions with Tata Steel have therefore concluded.“We have carefully evaluated Tata Steel IJmuiden and have concluded that an acquisition would be difficult for technical reasons. We cannot be sufficiently certain that we could implement our industrial plan

Invitation: Presentation of Ambea’s year-end 2020 results

Hosts: Benno Eliasson, acting CEO and CFO, and Jacob Persson, Head of Group Business Control and Investor Relations.On February 16th at 07:00 (CET) Ambea will publish its’ year-end 2020 results. In connection to the announcement, Ambea will host a telephone conference at 10:00 (CET) on Tuesday, February 16th. The presentation will be held in English and also available as webcast on www.ambea.com or direct link: https://edge.media-server.com/mmc/p/8z98xf9z To ensure that you are connected to the conference call, please dial in at least ten minutes before the start of the conference

Change in number of shares and votes in Camurus

Lund, Sweden — 29 January 2021 — During January 2021, 1,300 subscription warrants in Camurus’ subscription warrant series 2017/2020 have been exercised and as a consequence the number of shares and votes has increased by 1,417. Prior to the exercise, the total number of shares in Camurus amounted to 54,233,773, corresponding to 54,233,773 votes. As of 29 January 2021, the total number of shares in Camurus amounts to 54,235,190, corresponding to 54,235,190 votes. For more informationFredrik Tiberg, President & CEOTel. +46 (0)46 286 46 92fredrik.tiberg@camurus.com Fredrik Joabsson,

Ericsson reports fourth quarter and full-year results 2020

Fourth quarter highlights · Sales adjusted for comparable units and currency grew by 13% YoY mainly driven by sales in North East Asia, Europe and North America. Reported sales were SEK 69.6 (66.4) b. · Gross margin excluding restructuring charges improved to 40.6% (37.1%) with margin improvements in all segments. Reported gross margin improved to 40.6% (36.8%). · Operating income excluding restructuring charges improved to SEK 11.0 b. (15.8% operating margin) from SEK 6.5 b. (9.7% operating margin) mainly driven by Networks. Reported operating income was SEK 11.0 (6.1) b. ·

Year-end report January–December 2020

Return to underlying sales growth  KEY HIGHLIGHTS · Sales volumes increased by 5%  · Continued positive development of the ramp-up at Gruvön (KM7)  · Cost and efficiency programme exceeding target  · Strong operating cash flow · The Board of Directors proposes dividend of SEK 4.30 per share  Quarterly data · Net sales amounted to SEK 5 803 million (5 815). Excluding currency effects sales grew by 2% · Adjusted EBITDA* was SEK 568 million (618). Lower sales prices and higher maintenance costs were partly offset by lower fibre costs and a positive trend of the

BERGENBIO PRESENTS UPDATES FROM ONGOING PHASE II BEMCENTINIB COMBINATION STUDY IN REFRACTORY NSCLC AT WCLC 2020

·Bemcentinib in combination with pembrolizumab was well-tolerated and showed promising clinical activity in refractory lung cancer  Bergen, Norway, 29 January 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will today present an update from its Phase II study of bemcentinib in combination with anti-PD-1 therapy pembrolizumab (BGBC008) in refractory non-small cell lung cancer (NSCLC) patients at an oral presentation at the 2020 World Conference on Lung Cancer Singapore (WCLC).

Telia Company Year-end report January-December 2020

Strong cash flow generation  Fourth Quarter Summary · Net sales grew 2.7 percent to SEK 23,464 million (22,838) and like for like[4], net sales declined 1.9 percent. Service revenues grew 4.0 percent to SEK 19,765 million (19,007) and like for like[4], service revenues declined 2.1 percent. Adjusted EBITDA declined 5.5 percent to SEK 7,477 million (7,914) and like for like[4], adjusted EBITDA declined 6.6 percent. · COVID-19 had an estimated negative impact of SEK 400 million and SEK 200 million on service revenues and adjusted EBITDA, respectively. · Operating income

DNB Markets - Nexam Chemical: Significant Potential On The Horizon

Nexam Chemical continues to deliver on our forecasts and we are gaining confidence in its profitable growth journey. Growth remained impressive in Q4 at 46%, which we believe highlights the company’s significant potential beyond its 2022 sales target, driven by a good business case for the plastic industry to increase recyclability and better use of plastic materials. The stock is selling at a 2022e EV/sales of 2.6x. We have lifted our fair value to SEK13–17 (10–14).Details from the Q4 report. We find it encouraging that the company continues to deliver on our forecasts with Q4 sales 3%

Definitive strategic partnership agreements with Michelin delayed

All parts of the definitive agreements between Scandinavian Enviro Systems (publ) (“Enviro” or “The Company”) and Michelin concerning the announced strategic partnership have not yet been fully negotiated. Accordingly, Enviro will not be convening an Extraordinary General Meeting (EGM) for approval of the agreements in January as previously announced. Both Enviro and Michelin expect that the agreements will be fully negotiated in the near future. As previously communicated, the agreements must first be approved by Enviro’s owners at an EGM before they can enter into force. Notice of the EGM

Scandion Oncology adjusts the PANTAX pancreatic cancer study

Scandion Oncology A/S (“Scandion” or the “Company”) has submitted an amendment to the Danish Medicines Agency regarding the PANTAX study. The amendment is based on the learnings obtained from treating the first 12 patients in the CORIST study and will contribute to an optimization of the PANTAX clinical trials. The processing time for the amendment is expected to be approximately four weeks, which on top of the current impact of the COVID-19 pandemic could delay the planned readout from the study into Q4 2021.In Scandion’s PANTAX Ib study, patients with inoperable or metastatic pancreatic

There are no items matching the current filter
There are no more items matching the current filter
Back to top